About Grifols, S.A.
https://www.grifols.comGrifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions.
CEO
Jose Ignacio Abia Buenache
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2016-01-04 | Forward | 2:1 |
| 2012-12-11 | Forward | 21:20 |
ETFs Holding This Stock
Summary
Showing Top 3 of 17
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
BRANDES INVESTMENT PARTNERS, LP
Shares:29.12M
Value:$269.03M
CAPITAL WORLD INVESTORS
Shares:22.93M
Value:$211.84M
PERMIAN INVESTMENT PARTNERS, LP
Shares:17.45M
Value:$161.26M
Summary
Showing Top 3 of 257
About Grifols, S.A.
https://www.grifols.comGrifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.87B ▼ | $368.25M ▼ | $126.97M ▲ | 6.81% ▲ | $0.19 ▲ | $457.05M ▲ |
| Q2-2025 | $1.89B ▲ | $394.94M ▼ | $117.06M ▲ | 6.19% ▲ | $0.17 ▲ | $347.24M ▼ |
| Q1-2025 | $1.79B ▼ | $435.78M ▲ | $59.73M ▼ | 3.34% ▼ | $0.09 ▼ | $404.97M ▲ |
| Q4-2024 | $1.98B ▲ | $394.63M ▼ | $68.97M ▲ | 3.49% ▲ | $0.1 ▲ | $336.54M ▼ |
| Q3-2024 | $1.79B | $409.72M | $51.69M | 2.88% | $0.08 | $425.4M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $825.48M ▲ | $19.92B ▲ | $12.35B ▲ | $5.2B ▲ |
| Q2-2025 | $565.8M ▼ | $19.77B ▼ | $12.17B ▼ | $5.17B ▼ |
| Q1-2025 | $1.01B ▲ | $20.98B ▼ | $12.68B ▼ | $5.64B ▼ |
| Q4-2024 | $1B ▲ | $21.41B ▲ | $12.8B ▲ | $5.88B ▲ |
| Q3-2024 | $806.74M | $20.28B | $12.29B | $5.35B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $126.97M ▲ | $325.4M ▲ | $-122.68M ▼ | $-138.76M ▲ | $62.27M ▲ | $255.35M ▲ |
| Q2-2025 | $117.06M ▲ | $155.27M ▲ | $-107.65M ▲ | $-181.41M ▼ | $-194.13M ▲ | $95.02M ▲ |
| Q1-2025 | $59.73M ▼ | $135.47M ▼ | $-197.34M ▼ | $-133.65M ▼ | $-226.96M ▼ | $86.32M ▼ |
| Q4-2024 | $68.97M ▲ | $514.62M ▲ | $-178.31M ▲ | $-27.16M ▲ | $334.84M ▲ | $414.5M ▲ |
| Q3-2024 | $51.69M | $299.61M | $-196.4M | $-1.56B | $-1.47B | $215.36M |
CEO
Jose Ignacio Abia Buenache
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2016-01-04 | Forward | 2:1 |
| 2012-12-11 | Forward | 21:20 |
ETFs Holding This Stock
Summary
Showing Top 3 of 17
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
BRANDES INVESTMENT PARTNERS, LP
Shares:29.12M
Value:$269.03M
CAPITAL WORLD INVESTORS
Shares:22.93M
Value:$211.84M
PERMIAN INVESTMENT PARTNERS, LP
Shares:17.45M
Value:$161.26M
Summary
Showing Top 3 of 257